You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
With an emphasis on a practical, "how-to" approach, this comprehensive text addresses the most important and commonly performed procedures in gynecologic oncology surgery today. Written by leaders in the field, Principles of Gynecologic Oncology Surgery clearly describes the critical steps for each procedure, provides up-to-date information on the recent literature, and includes high-quality illustrations of anatomy and technique. - Covers hot topics such as Enhanced Recovery After Surgery (ERAS), sentinel lymph node mapping, and minimally invasive surgery (robotic surgery, advanced laparoscopic surgery, and single site surgery). - Includes expert coverage of reconstructive surgery, colorectal surgery, urology, and vascular surgery, each written by surgeon leaders in that particular field. - Addresses the diagnosis, management and prevention of surgical complications.
This book initiates the descriptions of the practical performance of different hysterectomies with conventional and robotically assisted laparoscopy, laparotomy and vaginal surgery. Laparoscopic hysterectomy has been out as an additional technique for hysterectomies for the last couple of decades. As the necessary light, augmentation and advanced skill has only been introduced into this already 200 year old surgical procedure within the last few decades by laparoscopy, the editors aim to look at the laparoscopic procedures followed by the traditional techniques of hysterectomy with laparotomy and vaginal surgery.
Ovarian cancer is an umbrella term for a collection of distinct disease entities (histotypes). Until now, the majority of research has focussed on the most common histotype, high-grade serous ovarian carcinoma (HGSOC), which accounts for 70% of cases. The less common histotypes – including endometrioid, clear cell, mucinous, low-grade serous, carcinosarcoma, and non-epithelial histotypes – have received far less research attention. Accordingly, while major advances in our understanding of HGSOC have led to molecularly-directed therapies that improve patient outcomes, progress in less common histotypes has lagged behind. Notably, many of the uncommon histotypes demonstrate resistance to conventional chemotherapy regimens, and their inherent biological differences suggest most are unlikely to respond to emerging molecular therapeutics designed to target the biology of common ovarian cancer types.
As cancer survival rates continue to improve, the number of patients living with cancer or after successful cancer treatment is increasing. Gynaecological cancers are potentially curable if caught in their early stages, and, therefore, quality of life after treatment is important. This is the first textbook to consider the prevention, diagnosis and management of psychological and physical treatment-induced morbidity in patients with gynaecological cancers. It is essential reading for all sub-specialty trainees in gynaecological oncology, as well as established consultants. It will appeal to consultants and trainees in all contributing specialties, including reproductive medicine, urology and uro-gynaecology, gastroenterology, colorectal surgery and psychology, as well as specialists in lymphoedema treatment.
Peritoneal surface malignancies (PSM) include a heterogeneous group of primary tumors, like peritoneal mesothelioma, and peritoneal metastases from various origins such as ovarian, gastric, colorectal, or appendicular cancers. Their pathophysiology is complex and still not fully elucidated. Historically, due to their dismal prognosis, peritoneal surface malignancies were considered a terminal condition and treated as such in palliative intent.. Surgery has become pivotal in the treatment of PSM and the development of specific techniques of cytoreductive surgery (peritonectomies, “en-bloc” resection) open up a new era of curative intent treatments.
This Research Topic is in collaboration with Colorectal Disease Centre . Over the past few years, there have been several advancements in proctology and colorectal surgery. Consequently, the need to have a tailored treatment for each patient emerged. This revolution involved both benign (haemorrhoidal disease, anal and pilonidal fistula, diverticulitis, fecal incontinence, inflammatory bowel diseases) and malignant (colorectal cancer) disorders. In addition, translational research and targeted therapies have improved the outcome and prognosis of patients with colorectal cancer. In the present Research Topic, we are encouraging experienced colleagues to submit original research articles, case studies, and review articles regarding the main points of debate of proctology and colorectal cancer.